US Patent 7157091 MAGE-A1 peptides presented by HLA class II molecules
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+357 characters)
Article
Patent abstract
The invention provides isolated HLA DRB1*15-binding peptides consisting of the amino acid sequence set forth as SEQ ID NO:7 with 0–10 amino acids added to either or both ends of the amino acid sequence set forth as SEQ ID NO:7, and an endosomal targeting signal comprising an endosomal targeting portion of human invariant chain Ii or LAMP-1.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07157091 MAGE-A1 peptides presented by HLA class II molecules US Patent 7157091 MAGE-A1 peptides presented by HLA class II molecules
Infobox
Patent Number
0715709100
Patent Number
715709100
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071570910
Date of Patent
January 2, 2007
0Patent Application Number
093360910
Date Filed
June 18, 1999
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071570910
Date of Patent
January 2, 2007
0Patent Application Number
093360910
Date Filed
June 18, 1999
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07157091 MAGE-A1 peptides presented by HLA class II molecules
Infobox
Is a
Patent jurisdiction
Patent number
07157091
Date of patent
January 2, 2007
Patent application number
09336091
Date Filed
June 18, 1999
Patent primary examiner
Find more entities like US Patent 7157091 MAGE-A1 peptides presented by HLA class II molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
